{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:57:42Z","timestamp":1793059062673,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"National Agency for Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejim.2026.107042","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T19:22:46Z","timestamp":1782588166000},"page":"107042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low-renin hypertension in incidental adrenal adenomas and response to aldosterone-targeted therapy: a prospective study"],"prefix":"10.1016","author":[{"given":"Thomas","family":"Uslar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6686-0463","authenticated-orcid":false,"given":"Benjam\u00edn","family":"Sanfuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7129-9543","authenticated-orcid":false,"given":"Roberto","family":"Olmos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3438-6085","authenticated-orcid":false,"given":"Alberth","family":"Burnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9104-9499","authenticated-orcid":false,"given":"Francisco J.","family":"Guarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Huete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Besa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1251-5832","authenticated-orcid":false,"given":"Marcelo","family":"And\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Majerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Cartes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-1468","authenticated-orcid":false,"given":"Alejandra","family":"Tapia-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian A.","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.","family":"Fardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6508-4052","authenticated-orcid":false,"given":"Fidel","family":"Allende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Solari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8655-4957","authenticated-orcid":false,"given":"Rene","family":"Baudrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejim.2026.107042_bib0001","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European network for the study of adrenal tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.ejim.2026.107042_bib0002","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2026.107042_bib0003","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/jch.13291","article-title":"Primary aldosteronism in patients with adrenal incidentaloma: is screening appropriate for everyone?","volume":"20","author":"Stavropoulos","year":"2018","journal-title":"J Clin Hypertens"},{"issue":"2","key":"10.1016\/j.ejim.2026.107042_bib0004","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/HYPERTENSIONAHA.123.21983","article-title":"Long-term follow-up of patients with elevated aldosterone-to-renin ratio but negative confirmatory test: the progression of primary aldosteronism phenotypes","volume":"81","author":"Buffolo","year":"2024","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ejim.2026.107042_bib0005","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.123.066389","article-title":"Subclinical primary aldosteronism and cardiovascular health: a population-based cohort study","volume":"149","author":"Hundemer","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2026.107042_bib0006","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1210\/clinem\/dgae145","article-title":"The spectrum of dysregulated aldosterone production: an international Human physiology study","volume":"109","author":"Parksook","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ejim.2026.107042_bib0007","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/M17-0882","article-title":"The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study","volume":"167","author":"Brown","year":"2017","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.ejim.2026.107042_bib0008","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1161\/HYPERTENSIONAHA.122.19134","article-title":"Cardiac structure and function across the spectrum of aldosteronism: the atherosclerosis risk in communities study","volume":"79","author":"Brown","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2026.107042_bib0009","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/CIRCULATIONAHA.124.073507","article-title":"Subclinical primary aldosteronism and major adverse cardiovascular events: a longitudinal population-based cohort study","volume":"152","author":"Goupil","year":"2025","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ejim.2026.107042_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023082","article-title":"Heightened cardiovascular risk in hypertension associated with renin-independent aldosteronism versus renin-dependent aldosteronism: a collaborative study","volume":"10","author":"Hu","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ejim.2026.107042_bib0011","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.ejim.2026.107042_bib0012","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/HYPERTENSIONAHA.120.15006","article-title":"Serum aldosterone concentration, blood pressure, and coronary artery calcium: the multi-ethnic study of atherosclerosis","volume":"76","author":"Inoue","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ejim.2026.107042_bib0013","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.ejim.2026.107042_bib0014","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2026.107042_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2024.05.033","article-title":"2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension","volume":"126","author":"Kreutz","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"12","key":"10.1016\/j.ejim.2026.107042_bib0016","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.ejim.2026.107042_bib0017","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an Endocrine Society clinical practice guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"38","key":"10.1016\/j.ejim.2026.107042_bib0018","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ejim.2026.107042_bib0019","article-title":"Como optimizar el diagn\u00f3stico funcional de los incidentalomas suprrarenales? Importancia de un estudio protocolizado","volume":"11","author":"Olmos","year":"2018","journal-title":"Rev Chil Endocrinol Diabet"},{"issue":"5","key":"10.1016\/j.ejim.2026.107042_bib0020","doi-asserted-by":"crossref","first-page":"e1946","DOI":"10.1210\/clinem\/dgac005","article-title":"Discriminative capacity of CT volumetry to identify autonomous cortisol secretion in incidental adrenal adenomas","volume":"107","author":"Olmos","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ejim.2026.107042_bib0021","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1210\/jc.2016-1963","article-title":"Dietary sodium restriction increases the risk of misinterpreting mild cases of primary aldosteronism","volume":"101","author":"Baudrand","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"10.1016\/j.ejim.2026.107042_bib0022","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1161\/CIRCULATIONAHA.115.016759","article-title":"Statin use and adrenal aldosterone production in hypertensive and diabetic subjects","volume":"132","author":"Baudrand","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejim.2026.107042_bib0023","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/ijms19020546","article-title":"The low-renin hypertension phenotype: genetics and the role of the mineralocorticoid receptor","volume":"19","author":"Baudrand","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.ejim.2026.107042_bib0024","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","article-title":"Primary aldosteronism: practical approach to diagnosis and management","volume":"138","author":"Byrd","year":"2018","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ejim.2026.107042_bib0025","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.mayocp.2023.04.023","article-title":"Primary aldosteronism: a pragmatic approach to diagnosis and management","volume":"98","author":"Dogra","year":"2023","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.ejim.2026.107042_bib0026","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ajh\/hpac079","article-title":"Primary aldosteronism: state-of-the-art review","volume":"35","author":"Vaidya","year":"2022","journal-title":"Am J Hypertens"},{"issue":"9","key":"10.1016\/j.ejim.2026.107042_bib0027","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2026.107042_bib0028","doi-asserted-by":"crossref","first-page":"948","DOI":"10.7326\/ANNALS-24-03153","article-title":"Confirmatory testing for primary aldosteronism : a study of diagnostic test accuracy","volume":"178","author":"Leung","year":"2025","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.ejim.2026.107042_bib0029","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.ejim.2026.107042_bib0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S2213-8587(24)00308-5","article-title":"Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort","volume":"13","author":"Yang","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7\u20138","key":"10.1016\/j.ejim.2026.107042_bib0031","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10337-014-2638-4","article-title":"LC-MS\/MS method for the simultaneous determination of free urinary steroids","volume":"77","author":"Allende","year":"2014","journal-title":"Chromatographia"},{"issue":"4","key":"10.1016\/j.ejim.2026.107042_bib0032","doi-asserted-by":"crossref","first-page":"e924","DOI":"10.1210\/clinem\/dgz315","article-title":"Classic and nonclassic apparent mineralocorticoid excess syndrome","volume":"105","author":"Carvajal","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ejim.2026.107042_bib0033","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.ejim.2026.107042_bib0034","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","article-title":"Resistant hypertension: detection, evaluation, and management: a scientific statement from the American heart association","volume":"72","author":"Carey","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2026.107042_bib0035","series-title":"Collaborating centrefor drug statistics methodology","year":"2024"},{"issue":"Suppl 1","key":"10.1016\/j.ejim.2026.107042_bib0036","first-page":"S20","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"17","key":"10.1016\/j.ejim.2026.107042_bib0037","first-page":"2735","article-title":"Diagnosis and management of the metabolic syndrome: an","volume":"112","author":"Grundy","year":"2005","journal-title":"Am Heart Assoc\/Natl Heart Lung Blood Inst Sci Statement Circ"},{"issue":"9","key":"10.1016\/j.ejim.2026.107042_bib0038","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.ejim.2026.107042_bib0039","article-title":"Clinical and metabolic characteristics and follow-up results of adrenal incidentalomas: a 10-year experience","volume":"16","author":"Arac","year":"2024","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.ejim.2026.107042_bib0040","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian society of endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ejim.2026.107042_bib0041","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.ejim.2026.107042_bib0042","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/ejendo\/lvae131","article-title":"Presentation and management of patients with adrenal masses: a large tertiary centre experience","volume":"191","author":"Suntornlohanakul","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"1065","key":"10.1016\/j.ejim.2026.107042_bib0043","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/postgradmedj-2013-132386","article-title":"Adrenal incidentalomas: management in British district general hospitals","volume":"90","author":"Davenport","year":"2014","journal-title":"Postgr Med J"},{"issue":"5","key":"10.1016\/j.ejim.2026.107042_bib0044","article-title":"Adrenal incidentalomas: are they being worked up appropriately?","volume":"6","author":"Sahni","year":"2016","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"12","key":"10.1016\/j.ejim.2026.107042_bib0045","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.3390\/biomedicines10123075","article-title":"Autonomous aldosterone secretion in patients with adrenal incidentaloma","volume":"10","author":"Kmie\u0107","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejim.2026.107042_bib0046","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/HYPERTENSIONAHA.125.24648","article-title":"Nationwide, pragmatic, direct-to-patient primary aldosteronism testing program","volume":"82","author":"Brown","year":"2025","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ejim.2026.107042_bib0047","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cen.13442","article-title":"Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism","volume":"87","author":"Nanba","year":"2017","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.ejim.2026.107042_bib0048","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/CIRCULATIONAHA.117.028201","article-title":"Age-related autonomous aldosteronism","volume":"136","author":"Nanba","year":"2017","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ejim.2026.107042_bib0049","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/js.2017-00134","article-title":"Aldosterone-producing cell clusters frequently harbor somatic mutations and accumulate with age in normal adrenals","volume":"1","author":"Omata","year":"2017","journal-title":"J Endocr Soc"},{"issue":"1","key":"10.1016\/j.ejim.2026.107042_bib0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International Histopathology Consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"10008","key":"10.1016\/j.ejim.2026.107042_bib0051","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ejim.2026.107042_bib0052","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1161\/HYPERTENSIONAHA.122.19377","article-title":"Performance of confirmatory tests for diagnosing primary aldosteronism: a systematic review and meta-analysis","volume":"79","author":"Leung","year":"2022","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.ejim.2026.107042_bib0053","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41371-023-00891-1","article-title":"Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis","volume":"38","author":"Shah","year":"2024","journal-title":"J Hum Hypertens"},{"issue":"4","key":"10.1016\/j.ejim.2026.107042_bib0054","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1210\/clinem\/dgae663","article-title":"Progressive 11beta-hydroxysteroid dehydrogenase type 2 insufficiency as kidney function declines","volume":"110","author":"Uslar","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejim.2026.107042_bib0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/endrev\/bnad024","article-title":"Biomarkers to guide medical therapy in primary aldosteronism","volume":"45","author":"Hundemer","year":"2024","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.ejim.2026.107042_bib0056","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac049","article-title":"Recalibrating interpretations of aldosterone assays across the physiologic range: immunoassay and liquid chromatography-tandem mass spectrometry measurements under multiple controlled conditions","volume":"6","author":"Brown","year":"2022","journal-title":"J Endocr Soc"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052600347X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052600347X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:21:08Z","timestamp":1784204468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362052600347X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":56,"alternative-id":["S095362052600347X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107042","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-renin hypertension in incidental adrenal adenomas and response to aldosterone-targeted therapy: a prospective study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.107042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107042"}}